Integrated Filing — IndAS



General information about company

Scrip Code 544339
NSE Symbol LAXMIDENTL
MSEI Symbol NOTLISTED
ISIN INE0WO601020
Name of company LAXMI DENTAL LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 10-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 04-02-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Integrated Dental Products
Start date and time of board meeting 10-02-2026   16:00:00
End date and time of board meeting 10-02-2026   17:33:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
It is not applicable for the Quarter ended December 31, 2025.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 4,845.10 15,282.00
Other income 200.60 603.50
Total income 5,045.70 15,885.50
2 Expenses
(a) Cost of materials consumed 1,003.40 3,066.00
(b) Purchases of stock-in-trade 531.00 1,760.10
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 22.20 191.40
(d) Employee benefit expense 2,009.10 5,702.40
(e) Finance costs 23.30 50.90
(f) Depreciation, depletion and amortisation expense 306.20 818.30
(f) Other Expenses
1 Other Expenses 823.00 2,341.90
Total other expenses 823.00 2,341.90
Total expenses 4,718.20 13,931.00
3 Total profit before exceptional items and tax 327.50 1,954.50
4 Exceptional items (515.60) (515.60)
5 Total profit before tax (188.10) 1,438.90
6 Tax expense
7 Current tax 181.20 589.10
8 Deferred tax (76.60) (97.20)
9 Total tax expenses 104.60 491.90
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (292.70) 947.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 103.70 307.00
16 Total profit (loss) for period (189.00) 1,254.00
17 Other comprehensive income net of taxes (15.20) (42.60)
18 Total Comprehensive Income for the period (204.20) 1,211.40
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,099.20 1,099.20
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.34 2.28
Diluted earnings (loss) per share from continuing operations -0.34 2.27
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.34 2.28
Diluted earnings (loss) per share from continuing and discontinued operations -0.34 2.27
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain/(loss) of net defined benefit plan (20.30) (56.90)
Total Amount of items that will not be reclassified to profit and loss (20.30) (56.90)
2 Income tax relating to items that will not be reclassified to profit or loss (5.10) (14.30)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (15.20) (42.60)





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K A & Associates LLP Yes 31-07-2027


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 16-01-2025
Amount Raised 69,805.80
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our Company NA 2,298.40 0.00 2,298.40 0.00
2 Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. NA 460.00 0.00 460.00 0.00
3 Funding the capital expenditure requirements for purcahse of new machinery for our company NA 4,350.70 0.00 697.30 0.00
4 Investment in our subsidiary Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery NA 2,500.40 0.00 34.60 0.00
5 General corporate purposes. NA 3,207.50 0.00 3,207.50 0.00


Signatory Details

Name of signatory Sameer Kamlesh Merchant
Designation of person Managing Director
Place Mumbai
Date 10-02-2026